Xometry (XMTR) officer sells 2,075 shares at $60 in 10b5-1 trade
Xometry, Inc. (XMTR) reported an insider stock transaction by its Chief Sales Officer on a Form 4.
Rhea-AI Filing Summary
Xometry, Inc. (XMTR) reported an insider stock transaction by its Chief Sales Officer on a Form 4. On 11/19/2025, the officer sold 2,075 shares of Class A common stock in an open-market transaction at a price of $60 per share, coded as an "S" sale. After this automatic sale, which was executed under a pre-arranged Rule 10b5-1 trading plan adopted at least 90 days earlier, the officer continued to beneficially own 71,348 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 2,075 | $60.00 | $125K |
Footnotes (1)
- F1. The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.
FAQ
What insider transaction did Xometry (XMTR) report in this Form 4?
The Chief Sales Officer of Xometry, Inc. (XMTR) reported selling 2,075 shares of Class A common stock in an open-market transaction on 11/19/2025.
Was the Xometry (XMTR) insider sale part of a Rule 10b5-1 trading plan?
Yes. The filing explains that the transaction was effected automatically under a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days before the trade date.
What is the relationship of the reporting person to Xometry (XMTR)?
The reporting person is an officer of Xometry, Inc., serving in the role of Chief Sales Officer, and is not listed as a director or 10% owner.
Does this Xometry (XMTR) Form 4 involve any derivative securities?
No derivative securities are reported as acquired, disposed of, or beneficially owned in the provided portion of the Form 4; only a common stock sale is shown in Table I.
AI-generated analysis. How Rhea-AI works. Not financial advice.